Chemoinformaics analysis of 3-Ethyl-5-(2-Ethylbutyl) Octadecane
Molecular Weight | 366.718 | nRot | 20 |
Heavy Atom Molecular Weight | 312.286 | nRig | 0 |
Exact Molecular Weight | 366.423 | nRing | 0 |
Solubility: LogS | -7.867 | nHRing | 0 |
Solubility: LogP | 11.071 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 54 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 26 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 79.4268 |
nHD | 0 | BPOL | 54.1732 |
QED | 0.188 |
Synth | 2.275 |
Natural Product Likeliness | 0.489 |
NR-PPAR-gamma | 0.007 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.01 |
HIA | 0.002 |
CACO-2 | -5.013 |
MDCK | 0.00000545 |
BBB | 0.008 |
PPB | 0.977139 |
VDSS | 3.589 |
FU | 0.00712407 |
CYP1A2-inh | 0.056 |
CYP1A2-sub | 0.184 |
CYP2c19-inh | 0.283 |
CYP2c19-sub | 0.071 |
CYP2c9-inh | 0.062 |
CYP2c9-sub | 0.962 |
CYP2d6-inh | 0.09 |
CYP2d6-sub | 0.019 |
CYP3a4-inh | 0.195 |
CYP3a4-sub | 0.061 |
CL | 5.321 |
T12 | 0.013 |
hERG | 0.35 |
Ames | 0.001 |
ROA | 0.009 |
SkinSen | 0.686 |
Carcinogencity | 0.01 |
EI | 0.931 |
Respiratory | 0.048 |
NR-Aromatase | 0.022 |
Antiviral | No |
Prediction | 0.686387 |